 Shares of Intercept Pharmaceuticals NASDAQ:ICPT moved higher by 3.6 in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 82.81 year over year to 0.33, which beat the estimate of 1.21. 